Psoriasis: Clinical Trials

18 trials for Psoriasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 5 unknown, 3 terminated, 2 recruiting. 18 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 118Completed 5, Unknown 5, Terminated 3, Recruiting 2, Withdrawn 2, Enrolling by invitation 1

Follow Psoriasis: new trials by email Literature Review of Psoriasis trials Research Report on Psoriasis

Trials (filtered) newest first · largest first

All 18 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Thera-Clean® Microbubbles System in Patients With Skin Diseases
TheraClean - Epidermolysis Bullosa, Ichthyosis
Early Phase 1Enrolling by invitationNorthwestern University202026-01-132026-11-09
Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque Psoriasis
Methotrexate, Tofacitinib - Psoriasis
Early Phase 1RecruitingLahore General Hospital752025-08-292025-12-03
Microbiome and Clinical Response to Probiotics and Methotrexate in Early Psoriasis: a Pilot Study
Probiotics and methotrexate, Methotrexate - Psoriasis (PsO)
Early Phase 1RecruitingAlexandria University242025-08-012025-09-11
Adherence to Otezla
Otezla - Standard Care, Reminder Text Intervention with apremilast, Extended Consultation for apremilast - Psoriasis
Early Phase 1WithdrawnWake Forest University Health Sciences2025-06-012025-05-29
Comprehensive Intervention of Diabetes and Psoriasis Comorbidity Prevention and Control
TCM comprehensive treatment, Western medicine - Psoriasis, Diabetes
Early Phase 1UnknownShanghai Yueyang Integrated Medicine Hospital3002024-07-012024-05-07
FAPI-PET/CT in Psoriatic Arthritis
68Ga-FAPI - Psoriatic Arthritis
Early Phase 1UnknownPeking Union Medical College Hospital202022-11-012023-01-17
Topical 1% Methotrexate Gel Versus Clobetasol Propionate in Patients With Psoriasis
topical 1% methotrexate gel, clobetasol propionate 0.05% ointment - Pilot Study, Psoriasis
Early Phase 1CompletedDr. Jose N. Rodriguez Memorial Hospital and Sanitarium22022-01-012024-08-16
Iontophoresis in Psoriasis
Activapatch intellidose 2.5 using active Iontophoresis, Activapatch intellidose 2.5 using inactive Iontophoresis, Dexamethasone - Psoriasis, Psoriasis Vulgaris
Early Phase 1WithdrawnWake Forest University Health Sciences2021-03-012021-04-01
COVID-19 Vaccination in Rheumatic Disease Patients
mRNA COVD19 vaccine - Systemic Lupus Erythematosus, Sjogren's Syndrome
Early Phase 1TerminatedMayo Clinic582021-02-152022-06-03
Triamcinolone Acetonide Injections in Mild-to-moderate Chronic Plaque Psoriasis With a Novel Needle-free Drug-delivery System
Med-Jet, Traditional Syringe - Psoriasis
Early Phase 1CompletedUniversity Hospitals Cleveland Medical Center132020-11-042023-09-18
Oral Chinese Herbal Medicine Concurrent With Secukinumab for Severe Plaque Psoriasis
Gu Ben Hua Yu Fang decoction (Chinese herbal medicine), Secukinumab Auto-Injector [Cosentyx] - Psoriasis
Early Phase 1UnknownGuangdong Provincial Hospital of Traditional Chinese Medicine102020-06-042021-03-02
Clinical Research on Treatment of Psoriasis by Human Umbilical Cord-derived Mesenchymal Stem Cells
Mesenchymal Stem Cells - Psoriasis
Early Phase 1UnknownCentral South University122019-02-202020-09-23
Safety and Pharmacokinetics of Sustained-release Depot Tacrolimus: A First-in-human Study
Sustained Release Injectable Tacrolimus - Organ Transplant Rejection, Psoriasis
Early Phase 1CompletedAuritec Pharmaceuticals82018-10-162019-08-13
Revitalization of Damaged Skin Due to Chronic Skin Diseases
ACE CSD - Chronic Eczema, Psoriasis
Early Phase 1UnknownAce Cells Lab Limited2002018-05-012018-04-02
Using an Internet Study to Improve Adherence for Psoriasis Patients
Internet Survey, fluocinonide 0.05% ointment - Psoriasis
Early Phase 1CompletedWake Forest University402012-10-012020-06-04
Cell Responses to IFN-gamma
Actimmune - Plaque Psoriasis
Early Phase 1TerminatedRockefeller University22010-07-012013-03-05
A Study to Test the Design, Functionality, and Ergonomic Features of the Autoinjector
Pre-filled Auto-injector Containing Placebo - Rheumatoid Arthritis, Psoriatic Arthritis
Early Phase 1CompletedCentocor, Inc.682007-12-012015-04-10
Study to Compare Different Light Therapies (Narrowband Ultraviolet B vs PUVA) for Hand and Foot Skin Diseases.
Narrowband Ultraviolet B (TL-01UVB) Therapy, Topical Psoralen plus ultraviolet A (PUVA) - Dermatitis, Psoriasis
Early Phase 1TerminatedMayo Clinic32005-03-012015-05-20

Narrower conditions

Arthritis, Psoriatic (3)  ·  Dermatitis, Atopic (2)  ·  Spondylitis, Ankylosing (2)  ·  Arthritis, Rheumatoid (1)  ·  Dermatitis (1)  ·  Diabetes Mellitus (1)  ·  Disease (1)  ·  Eczema (1)  ·  Epidermolysis Bullosa (1)  ·  Gout (1)  ·  Ichthyosis (1)  ·  Lupus Erythematosus, Systemic (1)  ·  Osteoarthritis (1)  ·  Sjogren's Syndrome (1)

Broader conditions

Skin Diseases, Papulosquamous (18)  ·  Skin and Connective Tissue Diseases (18)  ·  Skin Diseases (17)  ·  Immune System Diseases (4)  ·  Arthritis (3)  ·  Bone Diseases (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Joint Diseases (3)  ·  Musculoskeletal Diseases (3)  ·  Spinal Diseases (3)  ·  Spondylarthritis (3)  ·  Spondylarthropathies (3)  ·  Spondylitis (3)  ·  Ankylosis (2)

Interventions

Methotrexate (2)  ·  Ointments (2)  ·  68Ga-FAPI (1)  ·  Clobetasol (1)  ·  Dexamethasone (1)  ·  Ficusin (1)  ·  Fluocinonide (1)  ·  Probiotics (1)  ·  Therapeutics (1)  ·  apremilast (1)  ·  interferon gamma-1b (1)  ·  secukinumab (1)  ·  tofacitinib (1)

Sponsors

Mayo Clinic (2)  ·  Wake Forest University Health Sciences (2)  ·  Ace Cells Lab Limited (1)  ·  Alexandria University (1)  ·  Auritec Pharmaceuticals (1)  ·  Centocor, Inc. (1)  ·  Central South University (1)  ·  Dr. Jose N. Rodriguez Memorial Hospital and Sanitarium (1)  ·  Guangdong Provincial Hospital of Traditional Chinese Medicine (1)  ·  Lahore General Hospital (1)  ·  Northwestern University (1)  ·  Peking Union Medical College Hospital (1)  ·  Rockefeller University (1)  ·  Shanghai Yueyang Integrated Medicine Hospital (1)  ·  University Hospitals Cleveland Medical Center (1)

Countries

United States (10)  ·  China (3)  ·  Egypt (1)  ·  Pakistan (1)  ·  Philippines (1)  ·  Serbia (1)  ·  United Kingdom (1)

Top investigators

Steven R Feldman, MD, PhD (2)  ·  Amy Paller, MD (1)  ·  Chuanjian Lu, PhD (1)  ·  Dr. Diana Diana, MSc Dermatology (1)  ·  Ezzeldin A. Saleh, PhD (1)  ·  Gamaleldin A. Elsawaf, PhD (1)  ·  George J Atiee, MD (1)  ·  Hu Zeng, PhD (1)  ·  John Benjamin B Gochoco, MD (1)  ·  Mark D. Davis, M.D. (1)  ·  Maryam Fatima (1)  ·  Michelle Lowes, MD (1)  ·  Mohamed A. Alqasem, MSc (1)  ·  Neil Korman, MD, PhD (1)

Results publications

PMID 22224779, PMID 28588585, PMID 30793796, PMID 31453631, PMID 33926088, PMID 34769005, PMID 35304068, PMID 35927231, PMID 37908308, PMID 37953417, PMID 39576694

NIH funding

U44AI069674 (1)